MedImmune Ventures, Inc., 10% Owner at APPLIED GENETIC TECHNOLOGIES CORP (AGTC), bought 1,452,196 shares at $12.00 ($909K) on 2014-04-01, disclosed to the SEC on 2014-04-01.
Open-market purchase of $909k AGTC by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,376,461 | $0 | 0.0% |
| 2 | $12.00 | 75,735 | $909K | 100.0% |
| Total | $0.63 avg | 1,452,196 | $909K | 100% |
| Filing → |
| GTHX | SELL | 2017-12-05 | $5.3M | — | Filing → |
| GTHX | SELL | 2017-11-22 | $8.0M | — | Filing → |
| GTHX | BUY | 2017-05-24 | $1.1M | — | Filing → |